By: Vishnu Priyan
Bahrain-based AlAbraaj Restaurants Group is set for an IPO of 38 million shares on the Bahrain Bourse stock exchange.
Vishnu Priyan is a journalist specializing in the pharmaceutical and clinical trials industry. With his work featured in publications such as Pharmaceutical-Technology, Clinical Trials Arena, Medical Device Network, Verdict Foodservice, and Retail Insight Network, Vishnu covers a wide range of topics including drug development, licensing deals, clinical trial updates, and regulatory approvals.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Vishnu Priyan's coverage predominantly focuses on healthcare and pharmaceutical industry, with a particular emphasis on reporting press releases and private sector announcements. Given this focus, he is likely to be interested in receiving pitches related to new drug developments, clinical trials, and breakthroughs in medical research.
As his coverage includes a high percentage of press releases and private sector announcements, Vishnu may be open to receiving information about new products or initiatives from pharmaceutical companies or other relevant organizations within the healthcare industry.
It is also important to note that Vishnu's articles do not specify a geographic focus. Therefore, pitches can take an international perspective when reaching out with relevant stories related to bioscience, clinical trials, drug development or pharmaceutical companies.
This information evolves through artificial intelligence and human feedback. Improve this profile .